Purpose: To review the spectrum of imaging modalities commonly used in clinical practice for the diagnosis and management of uveal melanoma. Materials and Methods: Review of literature. Results: Various forms of ophthalmic imaging are useful in the characterisation and treatment planning of uveal melanoma. These include digital photography, ultrasonography, angiography and optical coherence tomography. Digital photography is useful for documenting the clinical findings for future comparison and response to treatment.
Lastly, newer developments in OCT allow assessment of associated features such as sub-retinal fluid, drusen or retinal atrophy.
The role of ancillary studies such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) (see Figure 1 ) and immunoscintigraphy is limited to atypical cases and surveillance for metastases.
Digital Photography
Digital slit-lamp and fundus cameras are useful for documenting the clinical features of uveal melanoma and provide a ready means for future comparison to monitor growth or response to treatment.
Iris Melanoma
Despite being the most common primary malignancy of the iris, melanoma in this location comprises only 3-10 % of uveal melanoma. 3 These tumours are either diffuse or circumscribed and tend to arise in the inferior portion of the iris. Iris melanomas vary in colour from light to dark brown and rarely can be amelanotic. In lightly pigmented tumours, intrinsic vascularity is usually visible. 4 When differentiating iris melanoma from nevi, features such as basal size >3 mm, prominent feeder vessels, secondary glaucoma or rapid growth are more suggestive of iris melanoma. Slit-lamp photography is useful for documenting the location and extent of tumour, tumour growth, tumour vascularity and associated features such as keratopathy, cataract or hyphema. In addition, gonioscopic slit-lamp photography is useful for documenting pigment dispersion, closure of the angle by tumour or pigment cells, or seeding of cells into the anterior chamber.
Ciliary Body Melanoma
In contrast to iris melanoma, ciliary body melanoma usually presents later in the fifth and sixth decade. 4 In general, ciliary body melanoma In addition to measuring the size and extent of a tumour, B-scan USG can also be used intra-operatively to confirm the position of the radioactive plaque, especially in posterior tumours where plaque placement may be technically challenging (see Figure 2 ).
A-scan Ultrasonography
Quantitative USG using standardised A-scan can help differentiate choroidal melanoma from other simulating entities by determining
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A 63-year-old Caucasian woman presented with a choroidal melanoma in the right eye (A). Bscan ultrasonography measured the lesion size as 10 x 11 x 3.2 mm (B). She elected for plaque treatment. B-scan ultrasonography was performed intra-operatively to confirm the location of the plaque, which is seen as an echolucent area with shadowing of orbital tissues (C).
reflectivity, internal structure and sound attenuation. Reflectivity is graded by the height of the spike on A-scan compared with a zero baseline and a 100 % spike of retina and all tissues equal or higher in density. Reflectivity can only be accurately determined when the A-scan probe is directed perpendicular to the lesion. Choroidal melanoma has a low-to-medium reflectivity and a high initial spike on standardised A-scan USG (see Figure 3 ). Sound attenuation is often observed at the base of the tumour. It is often difficult to obtain measurements of tumour size with A-scan, thus B-scan USG is usually preferred for tumour biometry.
Three-dimensional Ultrasonography
While performing standard 2D-USG, the operator is required to create a mental 3D representation of the tumour. The captured 2D images do not show tumour volume or surface characteristics. The images may not include the tumour apex in atypically shaped tumours. In contrast, 3D-USG collects echographic data from a large series of 2D-USG images that are quickly acquired and assembled using a computer algorithm. The resulting 3D images can be rotated, sliced or viewed in different planes. 7 Tumour biometry using 3D-USG in 42 patients with choroidal melanoma found this technique to be as reproducible as clinical examination and standard USG for measuring tumour diameter and height. 3D-USG was slightly more accurate in its ability to assess tumour volume as it accounts for geometry in a superior manner than standard USG. 8 3D-USG has a shorter examination time and does not require additional operator training. In one study of 44 intraocular mass lesions, abnormal Doppler shifts were demonstrated in 39 cases. 9 Using CDI, orbital haemangioma and
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A 75-year-old Caucasian man presented with a pigmented iris lesion inferonasally in the right eye (A). Gonioscopic slit-lamp photographs showed that the lesion extended into the trabecular meshwork with pigment dispersion (B). Ultrasound biomicroscopy demonstrated the extent of the tumour margins (C) and thickened ciliary body in the region of the tumour (D).
usually reveal patch-like hypofluorescence or hyperfluorescence. 4 They may also show hot spots caused by RPE leaks, which in the late phase, typically show leakage. In some cases of choroidal melanoma, intrinsic tumour circulation ('double circulation') may be visible.
Indocyanine-green Angiography
Compared to fluorescein angiography, indocyanine green has a peak absorption in the infrared spectrum, enabling it to penetrate the retinal layers and visualise the deeper choroidal circulation in a superior manner. 14 As a result, ICG is useful for visualising tumour vascularity (see Figure 6 ). In amelanotic melanomas, there is earlier 
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Optical Coherence Tomography
Anterior Segment Optical Coherence Tomography
Using light at 1310 μm with a rapid scanning technology, AS-OCT can image the anterior segment and is capable of obtaining a resolution of 17 μm with tissue penetration of 3-4 mm, 17 whereas ultrasound biomicroscopy has a lower resolution of 25 μm but higher penetration of 5-6 mm. As a result, AS-OCT is a useful tool for evaluating superficial lesions, particularly tumours anterior to the iris pigment epithelium (see Figure 7) . For larger lesions, or those arising in the iris pigment epithelium, shadowing occurs and posterior margin visibility is poor compared with ultrasound biomicroscopy. 13 For these reasons,
AS-OCT has limited use in the evaluation of uveal tumours.
mm (B). Indocyanine-green angiography was helpful in the diagnosis as it showed intrinsic vessels of the melanoma visible in the amelanotic region (C). The melanoma also demonstrated areas of autofluorescence within and along the tumour margins (D).

Spectral Domain Optical Coherence Tomography
Due to the fact that the choroid cannot be visualised using spectral domain OCT (SD-OCT), it is not helpful in the diagnosis of choroidal melanoma. However, SD-OCT can be used to document the retinal and RPE changes associated with choroidal melanoma or high-risk choroidal nevi (e.g. those with associated sub-retinal fluid) (see Figure 8 ).
OCT may serve to differentiate a choroidal melanoma from a melanocytoma, which demonstrates a superficial retinal component in melanocytoma.
Using 3D SD-OCT it was observed that, compared with choroidal nevi, choroidal melanomas more commonly presented with sub-retinal deposits, sub-retinal fluid and intraretinal edema. 18 However, visualisation is limited to the anterior aspect of the tumour with currently available OCT systems.
Enhanced Depth Imaging
Standard SD-OCT is unable to visualise the choroid and outer layers of the eye such as the sclera. Attempts to decrease scatter and absorption by the RPE, using 1050 nm light instead of the standard 800 nm light, unfortunately resulted in low scanning speeds and movement artefact and a deteriorated image quality. Recently, enhanced depth imaging (EDI), a new method of obtaining images of the layers beyond the RPE, has been developed. EDI is made possible by bringing the OCT scanner very close to the eye to obtain an inverted image. 19 EDI SD-OCT allows visualisation of the choroid and is useful for further characterising choroidal tumours.
EDI SD-OCT can assess choroidal tumours qualitatively (tumour outline, reflectivity, shadowing, inner sclera visibility) and quantitatively (diameter, thickness) (see Figure 9 ). 20 Choroidal melanoma has a band of high reflectivity in the choroid and demonstrates posterior shadowing.
SD-OCT can also assess and accurately measure small tumours that are undetectable by USG.
Metastatic Uveal Melanoma
While the use of imaging techniques for the diagnosis and documentation of primary uveal melanoma is fairly standardised, there is lack of consensus on protocols for screening for asymptomatic metastatic uveal melanoma. It has been suggested that liver function tests on a biannual basis combined with hepatic USG would detect up to 98 % of liver metastases. 24 The authors follow this recommendation in the management of their patients.
An 18-year-old Caucasian woman was referred for evaluation of a pigmented mass in the left eye. Examination revealed a circumscribed, green-brown choroidal mass with overlying sub-retinal fluid and orange pigmentation (A). Autofluorescence was visible in the red-free fundus photographs (B, C). B-scan ultrasonography showed the size to be 4 x 3 x 1.2 mm (D). Time-domain optical coherence tomography (OCT) revealed the presence of sub-retinal fluid but the choroid could not be visualised due to posterior shadowing (E). Spectral-domain OCT showed the anterior aspect of the choroidal nevus with overlying pigmentation and sub-retinal fluid (F).
Colour fundus photograph showing partially amelanotic nevus (A). B-scan ultrasonography showed a mildly elevated choroidal lesion (B). Time-domain optical coherence tomography (OCT) revealed a region of choroidal thickening (C). With enhanced depth imaging using the spectral domain
There is keen interest in identification of blood biomarkers for convenient identification of metastasis, treatment monitoring, treatment selection and possible risk stratification for adjuvant therapy. 
